JMID accepts online submissions; those wishing to submit a manuscript must register on our website. Please click here to register. If you already have a username and password, please click here.

The corresponding author must register to submit a manuscript and check the status of the submitted items. If the manuscript is incomplete, it will be sent back to the author for completion.

Article submission and article processing is entirely free of charge in JMID.

Overview of the publication and peer review processes

JMID aims to help all authors have an easy and efficient editorial process. Therefore, it is journal policy that our editorial team will evaluate all submitted items. First, the editorial team will evaluate the manuscript to decide whether it is ready for peer review. If it is ready for peer review, the manuscript will be assigned to one of our section editors, all of whom are experts in their fields.

Then the manuscript will be sent to three reviewers who are experts in the field of study relevant to the manuscript. They will evaluate whether the manuscript is scientifically well-designed and intelligible and whether the quality of writing is acceptable. The editorial team will decide whether or not to accept the submission based on the reviewers' recommendations. When a final decision is made, a decision letter will be sent to the corresponding author. Possible final decisions include:

· Acceptance without revision

· Acceptance with minor revisions

· Re-assessment after a major revision

· Declined

The authors will be informed if there are issues with the manuscript's formatting or the language quality. The authors will also be informed about how to get assistance to correct these issues.


Related Topics

According to the Uniform Requirements, all manuscripts should be prepared for manuscripts submitted to Biomedical Journals (http://www.icmje.org/). Manuscripts must only be submitted to the Journal of Microbiology and Infectious Diseases; they may not be submitted for publication elsewhere. All of the authors should sign a copyright transfer statement, and this document should accompany each submission.

Ethical Approval

All manuscripts submitted for publication should contain a declaration specifying that all prospective human studies have been approved by the Ethics Committee. The study should be performed following the ethical standards of the 2008 Declaration of Helsinki. In addition, the declaration should include a statement acknowledging that all participants gave informed consent before they participated in the study. If a study involves animals, it must have been approved by the animal ethics committee and performed according to the care and use of laboratory animals standards. A statement regarding these ethical issues should be included in the Method Section of the manuscript. This statement must include the name of the ethics approval body and the approval date.


Copyright agreement

After Acceptance for publication, all submitted materials become the possession of the Journal of Microbiology and Infectious Diseases. Upon Acceptance, the authors should provide a signed copyright transfer agreement that can be uploaded via the journal submission system or e-mailed to the publication office as a PDF. The journal upholds the copyright. Any of the materials published in the Journal of Microbiology and Infectious Diseases may be copied, replicated, or published elsewhere without the written permission of the journal.

When a manuscript is submitted to the journal, it must not be under review by any other journal or already accepted/published in any other journal or periodical. The JMID assumes that a submitted manuscript has been read and its content agreed to by all authors. All authors take responsibility for their reported findings.

Research manuscripts sponsored by pharmaceutical companies or commercial organizations should follow the Good Publication Practice Guidelines for Pharmaceutical Companies. In addition, the authors and sponsors are responsible for designing the study and reporting the results according to the ethical standards for industry-sponsored clinical trials and research.

JMID strongly suggests that authors follow the International Committee of Medical Journal Editors (ICMJE) recommendations for all types of publications and medical reports. These publications could include clinical trials/randomized controlled studies, reports of biomedical research, systematic reviews, meta-analyses of observational studies, qualitative studies, and diagnostic accuracy studies.

The authorship should be based on the ICMJE recommendations (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html). The author(s) should be mention those with other support and involvement in the preparation of the manuscript as well as financial support in the Acknowledgement section.

Submission Process

JMID aims to publish submissions worldwide, but all manuscripts must be written in American English. During the submission process, the manuscript should be assigned to the appropriate submission type.

Before submission, the corresponding author must register for a JMID account via the JMID website. The corresponding author will be responsible for all submission and revision procedures. When submitting a manuscript to JMID, the author must accept all of the terms and conditions of the journal publication.

Cover Letter

All manuscripts submitted to JMID must include a cover letter declaring that the manuscript has not been submitted (currently not under review) or accepted for publication elsewhere. In addition, this letter must state that all authors have made a remarkable contribution to the work and have read and approved the final version of the manuscript.

Potential Reviewers

The corresponding author should provide the names, e-mail addresses, work institutions, and areas of expertise of two potential reviewers. These reviewers should be qualified to review the manuscript.

Manuscript preparation

Organization of the Manuscript

Articles should be typed double spaced using twelve-point Times New Roman font.

Research articles, Clinical Trials, and Brief Reports should be organized in the following sections: Title page, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Figures, Figure Legends, Tables & captions, and Authors' contributions.

The text for Brief Reports should not exceed 2000 words, and the number of references, tables, and figures should be kept to a minimum.

Case reports should describe case diagnosis, investigations, or treatments of exceptional interest, highlighting novel and significant findings. They should include a maximum of two figures and two tables.

Clinical Images should describe an interesting case using one or more images (up to six). The authors should explain the case/images with a short text. The text must be 250 words or less.

Reviews: These summarize developments in areas related to infection that are of broad interest to the journal's target audience. These are usually invited, but authors identifying a need and wishing to submit a review article are welcome to contact the Editorial office. Authors are advised to contact the Editorial Office before the commencement of writing to ensure that a similar topic has not already been commissioned to another reviewer.

Manuscripts should be arranged in the following order; Title page, Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References, Tables, Figure Legends, Figures. All of these sections should run consecutively. The use of subheads is encouraged.

"Article File" should include manuscript entitle, Abstract(s), Key Words, Main Text, References, Tables, and Figure legends. Figures, pictures, or color Graphics should be submitted in JPG (or JPEG) format as separate files with different file names for each picture or figure. Please do not submit pictures and figures as embedded in the Word document file.

"Title Page": The title page should contain the Manuscript Title, Running Title, full names and affiliations of all authors, and complete contact information (including address, phone number, fax number, and e-mail) of the corresponding author.

Abstract: The abstract length in "Case Report" and "Letter to the Editor" should be ≤150 words and in an unstructured manner. In a Review article, Research article, and clinical trials, the abstract length must be ≤250 words. The abstract describes the aims, the results obtained from the presented data, and the conclusions. The abstract should be written in a structured manner, including Objectives, Materials and Methods, Results, and Conclusions subheadings. The length of the abstract should be ≤200 words in Brief Reports in a structured manner.

Keywords: Up to five keywords should be supplied following the abstract. The keywords should reflect the article's central topic and be incompatible with Medical Subject Headings (MeSH) (https://www.nlm.nih.gov/mesh/MeSHonDemand.html).

References: The number of references should be ≤30 for Research articles and Clinical trials, ≤20 for Brief Reports, and ≤15 for Case Reports, and Letters to the editor. References should be numbered consecutively in their appearance in the text and listed in numerical order. Journal titles should be abbreviated according to Index Medicus. The name of all authors should be written in the References if six or fewer authors exist. The first three authors and et al. should be given if the number of authors exceeds six. Citations should be indicated by their unique reference number in square brackets in the text. When multiple citations are within a single set of brackets, these should be separated by commas with no spaces between the comma and the next number. If there are three or more sequential citations, the numbers should be given as a range. Example: "…….previously described above [1,2-4,7]." References with correct punctuation should be as follows:

Journals:

Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev 2010; 23:412-441.

Schwartz S, Reisman A, Troke PF. The efficacy of voriconazole treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection 2011; 39:201-210.

Books:

Hatch DJ, Sumner E, Hellman J. The Surgical Neonate: Anaesthesia and Intensive Care, 3rd edn. London: Edward Arnold, 1994:120-125.

Chapter in a book: Motoyama EK. Respiratory physiology in infants and children. In: Motoyama EK, Davis PJ, eds. Smith's Anesthesia for Infants and Children, 5th edn. St. Louis: C.V. Mosby, 1990:11-76.

A paper published online but not (yet) in print can be cited using the Digital Object Identifier (DOI).

Tables and illustrations: Tables must be self-explanatory and must not duplicate information in the text. Each table must have a title and should be numbered in order of appearance in the text. In addition, any symbol and abbreviations used in the table body must be defined in a footnote to the table.

Cover File should include manuscript entitle, name of Authors, the affiliation of authors, Conflict of interest statement, correspondent Author and correspondence address, phone, fax, and E-mail addresses. In addition, the manuscript file should include Abstract, Main text, References, and Tables. Pictures (JPG files) and figures should be submitted as separate files for each picture and figure.

All manuscripts should be submitted online submission at using login Author Pathway / Online submission at www.jmidonline.org

Publication Ethics
Journal of Microbiology and Infectious Diseases / JMID (eISSN: 2146-9369) requires all authors and peer reviewers to declare any conflict of interest associated with the submission or review of an article.

Journal of Microbiology and Infectious Diseases / JMID (eISSN: 2146-9369) has adopted the Uniform Requirements for Manuscripts Submitted to Biomedical Journals 2001, as adopted by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org).

Conflict-of-interest statement

Authors are responsible for disclosing all financial and personal relationships that might bias their work. Financial relationships (such as employment, consultancies, stock ownership, honoraria, and paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal. To prevent ambiguity, authors must state explicitly in the letter accompanying the submitted manuscript whether potential conflicts do or do not exist.

Statement of informed consent

Analytical investigations on human participants must include a statement in the Methods section that participants gave their informed consent. It is journal policy that participant anonymity must be preserved in all cases. Research on experimental animals must be approved by an appropriate institutional ethics approval committee and the appropriate approval number must be stated in the Methods section.

Protection of human and animal rights

For experimental, clinical, and drug research an Ethics Committee report consistent with international agreements on human and animal rights (Helsinki Declaration of 1975, revised 2002 -http://www.wma.net/e/policy/b3.htm and “Guide for the care and use of laboratory animals - www.nap.edu/catalog/5140.html) and informed consent of patients is required.

Funding

Authors must include a statement in the Methods section that identifies any funding sources for their work.

Risk assessment

Authors must include a statement in the Methods section of compliance to any risk assessment procedures required by their organizations.

Peer-review process

All manuscripts are submitted for expert peer review. The journal uses a double-blind peer-review system, with two to three referees (members of the Editorial Committee and/or external consultants) independently evaluating all manuscripts. The referees will make Suggestions as to the acceptance, revision, or rejection of manuscripts. In certain cases, specialist peer reviewers (such as statisticians) will be used, for example, for review of study design features, the conduct of the study, presentation of data, statistical analysis, or conclusions. If the referees indicate that a manuscript should be revised, authors will be requested to revise the manuscript along the lines indicated by the referees. Occasionally, resubmitted manuscripts may undergo further peer review. Once revisions are completed and approved by the Managing Editor, the corresponding author is notified that an article has been accepted for publication. Rejected manuscripts will not be returned to authors. The average length of time from acceptance of the manuscript to publication is 6 months.

Copyright

Articles with original material are accepted for consideration with the understanding that, except for abstracts, no part of the data has been published, or will be submitted for publication elsewhere, before appearing in this journal. Authors are required to assign copyright to the Journal of Microbiology and Infectious Diseases / JMID (eISSN: 2146-9369) when their article is accepted for publication. The copyright assignment letter must be signed by all authors (or corresponding author) and a copy returned to the Managing Editor. Assignment of copyright protects the interests of both author and publisher. Although publication elsewhere is prohibited by such assignment of copyright, the material may be used by the author(s):

♦ for academic purposes (such as lecturing);
♦ for private use (excluding sale for profit);
♦ for teaching purposes;
♦ for professional advice to clients; and
♦ as part of non-commercial instructional publications.

Authors are required to warrant that the submitted material does not (or will not), to the best of their knowledge, infringe any copyright or other proprietary right or interest, or contain any statement which is false, libelous, or in any other way unlawful. Permission must be gained to reproduce any figure, table, or extensive extract (over 50 words) from any source that is owned or copyrighted by anyone other than the author of Journal of Microbiology and Infectious Diseases / JMID (eISSN: 2146-9369)